Abstract: The present invention relates to a compound according to general formula (I), which acts as an inhibitor of PqsR (the currently only known receptor for the Pseudomonas Quinolone Signal (PQS)); to a pharmaceutical composition containing one or more of the compound(s) of the invention; to a combination preparation containing at least one compound of the invention and at least one further active pharmaceutical ingredient; and to uses of said compound(s), including the use as a medicament, e.g. the use in the treatment or prophylaxis of a bacterial infection, especially a Pseudomonas aeruginosa or Burkholderia infection.

Abstract: The present invention relates to a compounds according to general formula (I), which acts as an inverse agonist of PqsR (the currently only known receptor for the Pseudomonas Quinolone Signal (PQS), sometimes also referred to as MvfR); to a pharmaceutical composition containing one or more of the compound(s) of the invention; to a combination preparation containing at least one compound of the invention and at least one further active pharmaceutical ingredient; and to uses of said compound(s), including the use as a medicament, e.g. the use in the treatment or prophylaxis of a bacterial infection, especially a Pseudomonasaeruginosa or Burkholderia infection.

Abstract: The present invention relates to a compound according to general formula (I), which acts as an inverse agonist of PqsR (the currently only known receptor for the Pseudomonas Quinolone Signal (PQS), sometimes also referred to as MvfR); to a pharmaceutical composition containing one or more of the compound(s) of the invention; to a combination preparation containing at least one compound of the invention and at least one further active pharmaceutical ingredient; and to uses of said compound(s), including the use as a medicament, e.g. the use in the treatment or prophylaxis of a bacterial infection, especially a Pseudomonas aeruginosa or Burkholderia infection.

Abstract: The present application pertains to methods of using indole-oxadiazole compounds of Formula I to modulate cannabinoid receptor activity: I In particular diseases, disorders or conditions that benefit from modulating cannabinoid receptor activity, such as non-alcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), schizophrenia, bipolar disorder, psychosis, metabolic syndrome, type-2 diabetes, dyslipidaemia, obesity, eating disorders, cardiovascular diseases and disorders, and other conditions as described herein, may be treated. Also included in the present application are certain novel compounds of Formula Ia and pharmaceutical compositions comprising these compounds.

Abstract: The present invention provides cystobactamides of formula (I): R1—Ar1-L1-Ar2-L2-Ar3-L3-Ar4-L4-Ar5—R2 and the use thereof for the treatment or prophylaxis of bacterial infections.

Abstract: The present invention relates to a compound according to general formula (I), which acts as an inhibitor of PqsR (the currently only known receptor for the Pseudomonas Quinolone Signal (PQS)); to a pharmaceutical composition containing one or more of the compound(s) of the invention; to a combination preparation containing at least one compound of the invention and at least one further active pharmaceutical ingredient; and to uses of said compound(s), including the use as a medicament, e.g. the use in the treatment or prophylaxis of a bacterial infection, especially a Pseudomonas aeruginosa or Burkholderia infection.

Abstract: The present invention provides cystobactamides of formula (I): R1—Ar1-L1-Ar2-L2-Ar3-L3-Ar4-L4-Ar5—R2 and the use thereof for the treatment or prophylaxis of bacterial infections.

Abstract: The present invention provides cystobactamides of formula (I) and the use thereof for the treatment or prophylaxis of bacterial infections.

Abstract: The present invention provides a method for the treatment or prophylaxis of bacterial infections by administering to a subject in need thereof an effective amount of a compound of formula.

Abstract: A stacked composite material and a method of preparation, wherein the stacked composite materials comprises of glass fiber layers sandwiched between nanocomposite layers. The nanocomposite layers comprise a nanofiller dispersed in a cured epoxy matrix, wherein the nanofiller is at least one of silicon carbide nanoparticles or aluminum oxide nanoparticles. Adjacent and noncontiguous glass fiber layers are oriented in a unidirectional orientation or a quasi-isotropic orientation.

Abstract: A stacked composite material having at least one glass fiber layer, at least two nanocomposite layers comprising multi walled carbon nanotubes dispersed in an epoxy matrix. Each glass fiber layer is sandwiched between two nanocomposite layers and the glass fiber layers are oriented in a unidirectional or a quasi-isotropic orientation with respect to adjacent and non-contiguous glass fiber layers in the stacked composite material. A method of preparing a stacked composite material comprising applying a nanocomposite layer onto a mold, overlaying a glass fiber layer on top of the nanocomposite layer, rolling an aluminum roller over the glass fiber layer, repeating the applying, overlaying, and rolling to form a stacked composite material.

Abstract: The present invention provides cystobactamides of formula (I) and the use thereof for the treatment or prophylaxis of bacterial infections: R1—Ar1-L1-Ar2-L2-Ar3-L3-Ar4-L4-Ar5—R2??(I):

Abstract: The present invention provides cystobactamides of formula (I) and the use thereof for the treatment or prophylaxis of bacterial infections.

Abstract: A stacked composite material and a method of preparation, wherein the stacked composite materials comprises of glass fiber layers sandwiched between nanocomposite layers. The nanocomposite layers comprise a nanofiller dispersed in a cured epoxy matrix, wherein the nanofiller is at least one of silicon carbide nanoparticles or aluminum oxide nanoparticles. Adjacent and noncontiguous glass fiber layers are oriented in a unidirectional orientation or a quasi-isotropic orientation.

Abstract: A stacked composite material having at least one glass fiber layer, at least two nanocomposite layers comprising multi walled carbon nanotubes dispersed in an epoxy matrix. Each glass fiber layer is sandwiched between two nanocomposite layers and the glass fiber layers are oriented in a unidirectional or a quasi-isotropic orientation with respect to adjacent and non-contiguous glass fiber layers in the stacked composite material. A method of preparing a stacked composite material comprising applying a nanocomposite layer onto a mold, overlaying a glass fiber layer on top of the nanocomposite layer, rolling an aluminum roller over the glass fiber layer, repeating the applying, overlaying, and rolling to form a stacked composite material.

Abstract: The present invention provides cystobactamides of formula (I) and the use thereof for the treatment or prophylaxis of bacterial infections:

Abstract: The solar-powered humidification-dehumidification desalination system includes a supply of saline/brackish water passing through a dehumidifier/condenser. The saline/brackish water is preheated in the dehumidifier/condenser due to the condensation process. A plurality of humidifying stages includes respective humidifiers and respective solar collectors. The solar collectors heat air, and the heated air passes through respective humidifiers to evaporate the preheated saline/brackish water, separating pure water from the brine. The humid air is reheated and recirculated through the humidifying stages and the dehumidifier, and the desalinated water from the dehumidifier via condensation is collected to and processed. The system recirculates the brine successively from each humidifier to the next for more efficient evaporation and less energy consumption.

Abstract: In a bubble-column vapor mixture condenser, a fluid source supplies a carrier-gas stream including a condensable fluid in vapor phase. The condensable fluid in liquid form is contained as a bath in a chamber in each stage of the condenser, and the carrier gas is bubbled through the bath to condense the condensable fluid into the bath. Energy from condensation is recovered to a coolant in a conduit that passes through the liquid in the stages of the condenser. The bubble-column vapor mixture condenser can be used, e.g., in a humidification-dehumidification system for purifying a liquid, such as water.

Abstract: In a bubble-column vapor mixture condenser, a fluid source supplies a carrier-gas stream including a condensable fluid in vapor phase. The condensable fluid in liquid form is contained as a bath in a chamber in each stage of the condenser, and the carrier gas is bubbled through the bath to condense the condensable fluid into the bath. Energy from condensation is recovered to a coolant in a conduit that passes through the liquid in the stages of the condenser. The bubble-column vapor mixture condenser can be used, e.g., in a humidification-dehumidification system for purifying a liquid, such as water.

Abstract: A novel database and method of classifying and searchably retrieving measurement data derived from a plurality of rock core and plug sample images that are analyzed to define their principal geostatistical attributes and characteristics, with the resulting analytical data being retrievably stored in a database, the method including calculating spatial variability of images, such as CT scan images, porosity images and other types of available images, quantifying the main image characteristics utilizing multi-azimuth variograms and simplified pattern recognition based on the histogram and variography analysis to thereby provide a means to correlate data from various geographical regions or fields by analyzing data which has the same variographic parameters.